Article

OBJECTIVE: To evaluate long-term outcomes of a noninvasive cortical stimulation
technology in the treatment of fibromyalgia (FM).
DESIGN: After trial follow-up
survey of subjects who had completed a randomized, controlled, double-blind study
of noninvasive cortical stimulation therapy some 45 months previously. SETTING:
General community. PARTICIPANTS: Patients with FM (N=69) who participated in the
previous study, 39 of whom were mailed surveys. INTERVENTIONS: Not applicable.
MAIN OUTCOME MEASURE: Changes in the Fibromyalgia Impact Questionnaire. RESULTS:
There was a 64% survey return rate. The total Fibromyalgia Impact Questionnaire
score was 52.6 at baseline, 35.7 at end of study, and 31.8 at follow-up (P<.001).
Subjects reported symptom improvements lasting at least 2 years, with a reduction
or elimination of medicine use and need to see physicians for FM. CONCLUSIONS:
A high percentage of patients with FM treated with noninvasive cortical stimulation
continued to experience worthwhile improvement at follow-up.
CI - Copyright (c) 2012 American Congress of Rehabilitation Medicine. Published by
Elsevier Inc. All rights reserved.

Langue : ANGLAIS